According to Genocea Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 71,120,000. At the end of 2022 the company had 71,120,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 71.12 M | 1.02% |
2021 | 70.4 M | 8.94% |
2020 | 64.62 M | 133.98% |
2019 | 27.62 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 7,840.10% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 3,491.35% | ๐บ๐ธ USA |
Novavax NVAX | 103,429,000 | 45.43% | ๐บ๐ธ USA |
Agenus
AGEN | 378,152,000 | 431.71% | ๐บ๐ธ USA |
iBio IBIO | 1,856,000 | -97.39% | ๐บ๐ธ USA |